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http://dx.doi.org/10.1016/j.stemcr.2016.04.007SUMMARYRegulation of prostate epithelial progenitor cells is important in prostate development and prostate diseases. Our previous study demon-
strated a function of autocrine cholinergic signaling (ACS) in promoting prostate cancer growth and castration resistance. However,
whether or not such ACS also plays a role in prostate development is unknown. Here, we report that ACS promoted the proliferation
and inhibited the differentiation of prostate epithelial progenitor cells in organotypic cultures. These results were confirmed by
ex vivo lineage tracing assays and in vivo renal capsule recombination assays. Moreover, we found that M3 cholinergic receptor
(CHRM3) was upregulated in a large subset of benign prostatic hyperplasia (BPH) tissues compared with normal tissues. Activation of
CHRM3 also promoted the proliferation of BPH cells. Together, our findings identify a role of ACS in maintaining prostate epithelial
progenitor cells in the proliferating state, and blockade of ACS may have clinical implications for the management of BPH.INTRODUCTION
Regulation of proliferation and differentiation of prostate
epithelial progenitor cells is important for the prostate
development process of branching morphogenesis and
prostate diseases. In the normal prostate, there are three
epithelial cell types: basal cells (p63+ and CK5+), luminal
cells (CK8+), and neuroendocrine cells (Synapthophysin+)
(Leong et al., 2008). Even though several studies have iden-
tified the multipotent potential of luminal cells under
castration conditions (Wang et al., 2009), in organoid
cultures or in renal capsule recombination assays (Chua
et al., 2014; Karthaus et al., 2014), it is also believed that
multipotent epithelial progenitor cells are located in the
basal cell compartment (Goldstein et al., 2010; Lawson
et al., 2007; Leong et al., 2008; Ousset et al., 2012), which
can differentiate into not only basal cells but also luminal
cells and neuroendocrine cells. Previous studies, including
the work from our group (Shou et al., 2001; Wang et al.,
2003, 2006b, 2008), have shown that various signaling
pathways can regulate epithelial progenitor cell prolifera-
tion and differentiation and, in turn, affect the formation
of prostate diseases (Shen andAbate-Shen, 2010). However,
whether or not there are additional important molecules
that regulate prostate epithelial progenitor cells is still
unclear.
Muscarinic receptors belong to the family of G-protein
coupled receptors. There are five members: CHRM1–668 Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativCHRM5 (Spindel, 2012). Activation of muscarinic recep-
tors by acetylcholine usually stimulates Ca2+ influx,
glandular secretion, and smoothmuscle contraction (Wess-
ler and Kirkpatrick, 2012). It was traditionally believed
that acetylcholine was predominantly synthesized in the
neuronal system. However, besides the neuronal cholin-
ergic system, there is also a widespread cholinergic system
in non-neuronal tissues, which has been identified in
airway epithelial cells, hematopoietic stem cells, small in-
testine epithelial cells, colon epithelial cells, mesenchymal
stem cells, and embryonic stem cells (Wessler and Kirkpa-
trick, 2012). The non-neuronal cholinergic signaling func-
tions in regulating the differentiation and proliferation
of embryonic stem cells (Landgraf et al., 2010), hematopoi-
etic stem cells (Serobyan et al., 2007), and small intestine
stem cells (Takahashi et al., 2014). In particular, our previ-
ous study demonstrated a role of autocrine cholinergic
signaling (ACS) in promoting prostate cancer growth and
castration resistance (Wang et al., 2015b). However,
whether or not such ACS also plays a role in regulating
proliferation and differentiation of prostate epithelial pro-
genitor cells is unknown.
In the present study, we discovered the existence of ACS
in the developing mouse epithelium. We used an organo-
typic culture system, which is free of functional nerve
fibers, to study the roles of ACS in regulating prostate
development. We further confirmed the results by lineage
tracing and renal capsule tissue recombination assay. Wers
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Prostate Epithelial Cells Express
Cholinergic Markers and Release Non-
neuronal Acetylcholine
(A) Immunostaining of TUJ-1 (red) in P5
mouse VP sections showing lack of nerve
fibers in epithelial tissues. Scale bar, 50 mm.
(B) Immunofluorescent images showing
epithelium-specific expressing of ChAT
(green) in P5 mouse VP tissue sections.
Scale bar, 100 mm.
(C) Western blotting analysis of ChAT and
VAChT proteins in various mouse tissues.
(D) Fluorometric detection of acetylcholine
in P5 mouse VPs after 2 days culture ex vivo
(n = 3 experiments).
(E) Fluorescent-activated cell sorting of
LinEpCAM+ epithelial cells and LinEpCAM
mesenchymal cells.
(F) Real-time PCR analysis of Chrm1-Chrm5
levels in P5 mouse epithelial cells and
mesenchymal cells (n = 3 experiments).
(G) Immunofluorescent staining of CHRM3 (green) and CK5 (red) in developing mouse VPs. Scale bar, 50 mm.
Data above were analyzed with Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate SEM.found that activation of ACS promoted prostate develop-
ment by enhancing the proliferation of epithelial pro-
genitor cells and preventing these progenitor cells from
differentiation. In addition, we demonstrated that these
effects were achieved through Ca2+/calmodulin signaling,
which could be blocked or reversed by a specific calmod-
ulin inhibitor, W-7. More importantly, we found that
CHRM3 was upregulated in a large subset of BPH tissues
comparedwith normal tissues. ACS promoted BPH cell pro-
liferation through Ca2+/calmodulin-signaling-mediated
phosphorylation of AKT. Taken together, our findings iden-
tify ACS as another important component that keeps pros-
tate epithelial progenitor cells in the proliferating state, and
blockade of ACS may have clinical implications for the
management of BPH.RESULTS
Existence of ACS in the Developing Mouse Prostate
Epithelium
Our previous study demonstrated the existence of func-
tional ACS in regulating prostate cancer growth and castra-
tion resistance (Wang et al., 2015b). However, whether
there is also an ACS in developing prostate epithelium
and how this ACS regulates prostate development has not
been determined. To examine the expression of cholinergic
components in developing prostates, we performed immu-
nofluorescent staining of TUJ-1 (a specific neuronal lineage
marker) and ChAT (choline acetyltransferase, a key enzyme
for the synthesis of acetylcholine) in P5 mouse ventralprostate (VP) sections. While a substantial number of
TUJ-1 immunoreactive nerve fibers were observed in the
mesenchyme, no nerve fiber was seen inside the epithe-
lium (Figure 1A). In sharp contrast, epithelial cells were
strongly immunoreactive for ChAT, a key enzyme respon-
sible for the synthesis of acetylcholine (Figure 1B). In addi-
tion, western blotting analysis confirmed the expression
of ChAT and vesicular acetylcholine transporter (VAChT)
in postnatal mouse VPs (Figure 1C). Furthermore, we per-
formed a fluorometric analysis to measure the synthesis
of acetylcholine in isolated mouse VPs. We found that
the isolated VPs could secrete acetylcholine after 2 days
in cultures (Figure 1D). Since the parasympathetic nerve
fibers were cut off during the dissection of VPs, most of
the nerve fibers had degenerated and lost their functions
after 2 days in culture (Figures S1A and S1B). Therefore,
the acetylcholine was synthesized and secreted by prostate
epithelial cells rather than from the nerve endings.
Activation of ACS needs not only the non-neuronal
acetylcholine, but also the expression of muscarinic recep-
tors in prostate epithelial cells. To examine the expression
of muscarinic receptors in developing mouse prostate, we
sorted prostate epithelial cells (lineageEpCAM+) from
mesenchymal cells (lineageEpCAM) by fluorescence-
activated cell sorting (FACS) (Figure 1E) and measured the
expression of muscarinic receptors, Chrm1-Chrm5. Real-
time PCR analysis indicated that all five subtypes of musca-
rinic receptors are expressed in the prostate epithelial cells.
While Chrm2 and Chrm4 were expressed at higher levels
in the mesenchymal cells than in the epithelial cells (Fig-
ure 1F), expression levels of Chrm1 and Chrm5 did notStem Cell Reports j Vol. 6 j 668–678 j May 10, 2016 669
Figure 2. ACS Regulates the Proliferation
and Differentiation of Prostate Epithelial
Progenitor Cells
P5 mouse VPs were cultured for 48 hr in
an organotypic culture system with 10 mM
carbachol or 10 mM darifenacin prior to the
following experiments.
(A) Organotypic cultures of VPs demon-
strated that activation of ACS by carbachol
(10 mM) promoted prostatic branching
morphogenesis, whereas inhibition of ACS
by darifenacin (10 mM) inhibited prostatic
branching morphogenesis. Scale bar, 1 mm.
(B) Statistical analysis of bud number by
counting the branching tips in each prostate
(n = 10 different VPs).
(C and D) Activation of muscarinic receptors
increased thepercentageof p63 (red) andEdU
(green) double-positive proliferating epithe-
lial progenitor cells. Data were collected by
calculating the percentage of EdU+ cells in
p63+ basal cells or p63 luminal cells (n = 6
different VPs). Scale bar, 25 mm.
(E and F) Co-immunostaining of basal cell
marker CK5 (red) and luminal cell marker CK8
(green) showing more basal cells among
total epithelial cells in carbachol-treated
prostates. Data were collected by counting
the number of CK5+ basal cells and CK5CK8+ luminal cells in each duct (n = 5 different VPs). Scale bar, 25 mm.
(G and H) Flow cytometry analysis of EpCAM+CK5+ positive basal cells in total EpCAM+ epithelial cells (n = 3 experiments).
Data above were analyzed with Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate the SEM.show much difference between the epithelium and the
stroma. In sharp contrast, Chrm3 was more abundant in
the epithelium than in the mesenchyme (Figure 1F).
Immunofluorescent staining also confirmed the epithe-
lium-specific expression of Chrm3 in P5 mouse VP sections
(Figure 1G). All these data demonstrate the presence of
acetylcholine, ChAT, VAChT, and muscarinic receptors in
the developing mouse prostate epithelium. Consistent
with our previous study that identified the existence of
ACS in human prostate epithelial cancer cells, these find-
ings together suggest that there is an ACS in the developing
mouse prostate epithelium.
ACS Regulates the Proliferation and Differentiation of
Epithelial Progenitor Cells in Prostate Postnatal
Development
To investigate the possible functions of ACS in regulating
prostate postnatal development, we performed organo-
typic cultures as previously described, as a convenient
working system (Leong et al., 2008; Wang et al., 2008).
To validate the organotypic cultures, we compared the
expression patterns of ACS molecules in freshly dissected
tissues versus the organotypic cultures. As shown in Fig-670 Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016ures S1C and S1D, we found that the cellular expression
pattern of CHRM3 and ChAT in the 2-day organotypic
cultures was the same as freshly dissected prostate tissues
(Figures 1B and 1G). Real-time PCR analysis also demon-
strated that the expression of cholinergic-signaling-related
genes remained unchanged (Figure S1E). These data
validate that the organotypic culture system is reliable to
study the roles of ACS in regulating prostate postnatal
development.
For organotypic cultures, postnatal day 5 (P5) mouse VPs
were isolated and cultured in the presence of 10 mMmusca-
rinic receptor agonist carbachol. The branching morpho-
genesis was analyzed by counting the number of branching
tips. We found that activation of muscarinic receptors by
carbachol promoted prostatic branching morphogenesis
(Figures 2A and 2B). Next, we wanted to study whether
blockade of ACS also affected prostatic branching morpho-
genesis. Since the expression of Chrm3 was significantly
higher in the epithelial cells than in themesenchymal cells
(Figure 1F), we treated the isolated VPs with darifenacin, a
selective CHRM3 antagonist. We found that inhibition of
CHRM3 by darifenacin effectively reduced the formation
of new buds (Figure 2B). In addition, we examined the
effects of AFDX-384, a specific antagonist for CHRM2
and CHRM4, on prostatic branching morphogenesis. As
Chrm2 and Chrm4 were more abundant in the mesen-
chyme than in the epithelium, compared with the control
group, AFDX-384 did not significantly affect prostatic
branching morphogenesis (Figures S2A and S2B). In the
organotypic cultures of dorsal-lateral prostate, we also
confirmed that carbachol and darifenacin promoted or
inhibited prostatic branching morphogenesis, respectively
(Figures S2C and S2D). These data suggest that ACS regu-
lates prostate development throughCHRM3 that expressed
on the epithelial cells.
To understand how ACS affects epithelial cell prolifera-
tion and differentiation and whether it exerts its effect
via influencing the proliferation of epithelial progenitor
cells, we co-stained EdU with a basal cell marker, p63.
We found that carbachol promoted the proliferation of
both basal cells and luminal cells, whereas darifenacin in-
hibited the proliferation of epithelial cells (Figures 2C and
2D). To examine the differentiation of epithelial progeni-
tor cells, we performed dual immunostaining for basal
cell marker CK5 and luminal cell marker CK8. We counted
the number of basal cells and luminal cells in each duct.
Compared with the control group, we observed more
CK5+ basal cells in carbachol-treated VPs and less CK5+
basal cells in darifenacin-treated VPs (Figures 2E and 2F).
Intriguingly, the number of luminal cells in each duct
did not change significantly (Figure 2F). Given that
luminal cells can be derived from either the proliferation
of luminal cells or the differentiation of basal cells (Wang
et al., 2014), the unchanged total number of luminal cells
supports the idea that activation of ACS enhances basal
cells by promoting basal cell proliferation and inhibiting
the differentiation of basal progenitor cells. One plausible
interpretation is that the reduction in the number of
luminal cells that are differentiated from basal cells
matches the enhanced number of luminal cells due to
increased luminal cell proliferation, which leads to an
unchanged total number of luminal cells.
In addition, we performed unbiased flow cytometry anal-
ysis to measure the percentage of CK5+ basal cells in
EpCAM+ total epithelial cells. Similarly, flow cytometry
analysis showed a higher percentage of basal cells in carba-
chol-treated VPs and less basal cells in darifenacin-treated
VPs (Figures 2G and 2H). Consistently, we detected a
higher level of Krt5 mRNA in carbachol-treated cultures
(Figure S3A). Moreover, examination of the expression
levels ofMki67 and cell cycle promoter Ccnd1 also showed
results in accordance with the proliferating status of VPs in
different groups (Figure S3B). These data together indicate
that ACS affects prostate postnatal development through
regulating the proliferation and differentiation of epithe-
lial progenitor cells.Lineage Tracing Assay Confirms that ACS Regulates
the Differentiation of Epithelial Progenitor Cells
Lineage tracing analysis using specific transgenic mouse
lines is a useful tool to study the differentiation of prostate
epithelial progenitor cells (Blackwood et al., 2011; Blanpain
and Simons, 2013; Ousset et al., 2012; Wang et al., 2014).
We performed lineage tracing of CK14-expressing basal
cells to verify the regulation of ACS on the differentiation
of epithelial progenitor cells (Figures 3A and 3B). VPs
were dissected from P5 CK14-CreERT/Rosa26-RFP mice
and cultured as described above. To activate CreERT, iso-
lated VPs were incubated with 100 nM 4-hydroxytamoxi-
fen (4-OHT) for 12 hr (Sato et al., 2009). The addition of
4-OHT can induce Cre activity in the nucleus and label
the CK14 expressing cells with RFP (Wang et al., 2014).
Thirty-six hours after the induction, we observed that
RFP only labeled CK5+ basal cells (Figure 3C). Then, we
treated these VPs with carbachol or darifenacin for 48 hr.
Forty-eight hours after the treatment, we performed frozen
sectioning and co-stained the tissue sections with RFP and
a basal cell marker, CK5. We observed both RFP+CK5+ basal
cells and RFP+CK5 luminal cells in the tissue sections (Fig-
ure 3D), and we considered RFP+CK5 luminal cells as
differentiated cells that originated from the RFP-labeled
basal cells based on the RFP-lineage marker. We analyzed
the percentage of RFP+CK5 cells over the total RFP-labeled
cells and found that carbachol decreased the percentage of
RFP+CK5 luminal cells, whereas darifenacin increased the
percentage of RFP+CK5 luminal cells (Figures 3E and 3F).
These results further confirm that ACS regulates the differ-
entiation of prostate epithelial progenitor cells.
Knockdown of Chrm3 Promotes the Differentiation of
Epithelial Progenitor Cells in Renal Capsule Tissue
Recombination Assays
To further examine the effects of ACS on epithelial cell
differentiation in vivo, we carried out the renal capsule
recombination assay, which is a useful model to examine
the differentiation of epithelial progenitor cells (Cunha,
1973; Xin et al., 2003). We sorted the epithelial cells from
P5mouse VPs with LinEpCAM+ (Figure 1E). Sorted epithe-
lial cells were cultured in low-binding-surface 6-well plates
and transfected with sh-Chrm3 lentivirus (Figure 4A). Two
days later, puromycin (2 mg/ml) was added to eliminate un-
transfected cells. The transfection efficiency was examined
bywestern blot (Figure 4B). Successfully transfected epithe-
lial cells were combined with rat urogenital sinus mesen-
chymal (UGSM) cells and engrafted under the renal capsule
of BALB/c nude mice. Six weeks later, we collected the
kidneys and found that knockdown of Chrm3 obviously
reduced the size and weight of the recombinants (Figures
4C and 4D). The epithelium-specific staining of RFP
confirmed that the regenerated epithelial cells originatedStem Cell Reports j Vol. 6 j 668–678 j May 10, 2016 671
Figure 3. In Vitro Lineage Tracing Assay
Confirms that ACS Regulates the Differen-
tiation of Epithelial Progenitor Cells
(A and B) Schematic illustration and time
course of the lineage tracing strategy.
(C) Co-immunostaining of RFP and basal
cell marker CK5 (green) in VPs treated with
4-OHT for 48 hr. RFP only labeled CK5+ basal
cells. Scale bar, 50 mm.
(D) Co-immunostaining of RFP and basal
cell marker CK5 (green) in VPs treated with
4-OHT for 96 hr. Note that genetically
labeled RFP+CK5+ basal cells could differen-
tiate to RFP+CK5 luminal cells. Scale bar,
100 mm.
(E and F) Statistical analysis of RFP+CK5
luminal cells over the total RFP-labeled
cells. By counting cells from approximately
20 randomly acquired images from three
different VPs, we had 2,136 RFP+ cells in
the control group, 1,783 RFP+ cells in the
carbachol group, and 1,988 RFP+ cells in the
darifenacin group. Note that compared with
the control group, carbachol inhibited the
differentiation of RFP-labeled basal cells,
whereas darifenacin promoted the differen-
tiation of basal cells.
Data above were analyzed with Student’s
t test. **p < 0.01, ***p < 0.001. Error bars
indicate the SEM.from the implanted epithelial cells (Figure 4E). Immunoflu-
orescent staining of CK5 and CK8 revealed that knock-
down of Chrm3 reduced the percentage of basal cells in
total epithelial cells (Figure 4F). These findings indicate
that inactivation of ACS promoted the differentiation of
epithelial progenitor cells in vivo.
The Effects on Epithelial Progenitor Cells by ACS Are
Achieved via Ca2+/Calmodulin-Signaling-Mediated
Phosphorylation of AKT
A common indicator for activation of ACS is calcium
influx, as shown in prostate cancer cells (Wang et al.,
2015b). To verify whether ACS also stimulated calcium
influx in developing mouse prostate, we employed the
Ca2+ indicator Fluo-4/AM to detect Ca2+ influx. Consid-
ering that small molecules were less permeable to tissues
than monolayer cells, we increased the concentration of
carbachol to 50 mM rather than 10 mM used in tissue cul-
tures. In P3 VPs, the addition of carbachol obviously
increased Ca2+ influx (Figures S4A and S4B), whereas sup-
pression of CHRM3 by darifenacin largely decreased Ca2+
influx induced by carbachol (Figure S4C). In addition, inhi-672 Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016bition of Ca2+/calmodulin signaling by a calmodulin-
specific antagonist N-(6-aminohexyl)-5-chloro-1-naphtha-
lenesulfonamide hydrochloride (W-7, 5 mM) effectively
inhibited the enhanced branchingmorphogenesis induced
by carbachol (Figures 5A and 5B) in the organotypic pros-
tate cultures. These data together indicate that ACS regu-
lates prostate postnatal development through calcium
singling.
To further confirm the involvement of Ca2+/calmodulin
signaling during ACS-regulated epithelial progenitor cell
proliferation and differentiation, we performed immuno-
fluorescent staining on tissue sections, which allows assess-
ment of the detailed numbers of basal and luminal cells.
The EdU incorporation assay showed decreased prolifer-
ating epithelial cells in W-7-treated cultures (Figures 5C
and 5D). Co-immunofluorescent staining of CK5 and
CK8 indicated that the addition of W-7 promoted the dif-
ferentiation of progenitor cells into luminal cells (Figures
5E and 5F). Real-time PCR analysis also showed decreased
Krt5 mRNA expression in W-7-treated prostates (Fig-
ure S5A). Compared with carbachol-treated cultures, W-7
decreased the expression ofMki67 and Ccnd1 (Figure S5B).
Figure 4. Knockdown of Chrm3 Promotes
the Differentiation of Epithelial Progeni-
tor Cells in the Renal Capsule Tissue
Recombination Assay
(A) Transfection of epithelial cells by
scramble and sh-Chrm3 lentivirus. Scale bar,
50 mm.
(B) Detection of CHRM3 knockdown effi-
ciency by western blot.
(C) Renal capsule recombinants collected at
6 weeks.
(D) Knockdown of Chrm3 decreased the
weight of the recombined grafts (n = 6
grafts). Data were analyzed with Student’s
t test. **p < 0.01. Error bars indicate
the SEM.
(E) Co-staining of RFP (red) and CK5 (green)
confirmed that the regenerated epithelial
cells originated from the implanted cells.
Scale bar, 50 mm.
(F) Co-immunostaining of basal cell marker
CK5 (red) and luminal cell marker CK8
(green). Scale bar, 100 mm.To further confirm that ACS’s regulation on the differenti-
ation of epithelial progenitor cells is achieved via calcium
signaling, we performed an ex vivo lineage tracing assay.
We used VPs from CK14-CreERT/Rosa26-RFP mice and
treated them with carbachol andW-7. We co-stained tissue
sections with RFP and CK5 and found that blockade of
calmodulin by W-7 increased the percentage of differenti-
ated RFP+CK5 cells over the total RFP-labeled cells (Fig-
ure 5G), indicating that W-7 promoted the differentiation
of epithelial progenitor cells. These results clearly indicate
that ACS’s regulation of prostate development is mediated
through calcium signaling.
AKT, also known as protein kinase B (PKB), is a serine/
threonine-specific protein kinase that plays a key role in
themaintenance of epithelial progenitor cells. Continuous
activation of AKT through the knockout of protein phos-
phatase and tensin homolog (PTEN) leads to increased
epithelial progenitor cells in the prostate gland (Mulhol-
land et al., 2009; Wang et al., 2006a) and the mammary
gland (Korkaya et al., 2009). Since our previous studydemonstrated that activation of ACS stimulated AKT phos-
phorylation in prostate cancer cells (Wang et al., 2015b),
we next wanted to determine whether ACS regulates pros-
tate development through regulating the phosphorylation
of AKT. Immunofluorescent staining of phosphor-AKT
(Ser473) indicated that AKT was abundantly activated in
developing prostate epithelial cells (Figure S6). While
carbachol stimulated the phosphorylation of AKT, both da-
rifenacin and W-7 effectively reversed carbachol-induced
AKT activation (Figures 5H and 5I). These results together
suggest that ACS regulates prostate development and
epithelial progenitor cell maintenance via Ca2+/calmod-
ulin-mediated phosphorylation of AKT.
Aberrant Activation of ACS PromotesHumanBPHCell
Proliferation
To extend our findings from mouse prostate development
to human prostate diseases such as BPH, we first wanted
to identify the existence of ACS in normal human prostate
epithelium. We performed immunostaining of TUJ1 andStem Cell Reports j Vol. 6 j 668–678 j May 10, 2016 673
Figure 5. ACS Maintains the Proliferation
and Differentiation of Epithelial Progeni-
tor Cells in a CaM-Dependent Manner
(A–F) Mouse VPs were cultured for 48 hr
in an organotypic system with 10 mM
carbachol or 5 mM W-7 prior to the following
experiments. (A) CaM inhibitor W-7 (5 mM)
reduced branching morphogenesis induced
by carbachol. Scale bar, 1 mm. (B) Statistical
analysis of bud initiation in prostates with
different treatments (n = 3 different VPs).
(C and D) Co-immunostaining of p63 (red)
and EdU (green) indicated that inhibition of
CaM reduced the proliferation of basal cells
induced by carbachol. The dashed lines
depict the outlines of the epithelial cells.
Quantification was performed by calculating
the percentage of EdU+ cells in p63+ basal
cells or p63 luminal cells (n = 3 different
VPs). Scale bar, 50 mm. (E and F) Co-immu-
nostaining of CK5 (red) and CK8 (green)
showed that W-7 could reduce the number of
basal cells in total epithelium. Data were
collected by counting the number of CK5+
basal cells and CK5CK8+ luminal cells in
each duct (n = 3 different VPs). Scale bar,
50 mm.
(G) Compared with the carbachol group
(245/1783 RFP+ cells), W-7 (367/1731 RFP+
cells, n = 3 different VPs) decreased the
percentage of CK5+ cells in the total RFP-
labeled cells.
(H and I) Western blotting analysis of AKT
activation in cultured VPs. While carbachol
increased the phosphorylation of AKT, both
darifenacin and W-7 could effectively block
the carbachol-induced activation of AKT.
Data above were analyzed with Student’s
t test. *p < 0.05, **p < 0.01, ***p < 0.001.
Error bars indicate the SEM.ChAT in normal human prostate tissue sections. As shown
in Figure 6A, human prostate epithelial cells were not
directly innervated by TUJ-1+ nerve fibers, however, the
epithelial cells showed strong ChAT immunoreactivity.
Because our previous study had confirmed that CHRM3
played an important role in ACS-mediated prostate cancer
growth and castration resistance, we compared mRNA
expression of CHRM3 in normal and BPH human prostate
samples.We found that the expression ofCHRM3 varied lit-
tle among normal prostate samples (Figure 6B). Compared
with normal samples, however, the expression of CHRM3
was upregulated in a large subset of the BPH samples (15
of 22 samples). Of the 15 samples in which CHRM3 was
upregulated, ten showed enhanced CHRM3 expression
with more than 5-fold changes (Figure 6B).674 Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016Next, we wanted to explore the consequence of disor-
dered ACS in human BPH. We first detected calcium
influx in BPH1 cells and found that blockade of
CHRM3 by darifenacin could inhibit carbachol-induced
calcium influx (Figure 6C). In addition, we examined
the effects of ACS on the proliferation of human BPH1
cells, a transformed, non-tumorigenic cell line derived
from human BPH tissue (Hayward et al., 1995). Whereas
carbachol stimulated BPH1 cell proliferation, both dari-
fenacin and W-7 counteracted the enhanced cell pro-
liferation induced by carbachol (Figure 6D). Further-
more, we found that both darifenacin and W-7 also
effectively inhibited the phosphorylation of AKT stimu-
lated by carbachol (Figure 6E). These findings together
suggest that aberrant activation of ACS promotes BPH
Figure 6. Aberrant Activation of ACS Pro-
motes BPH Cell Proliferation via Ca2+/
Calmodulin Signaling-Dependent Phos-
phorylation of AKT
(A) Immunostaining of TUJ1 and ChAT in
normal human prostate tissue sections.
Scale bar, 100 mm.
(B) Real-time PCR analysis of CHRM3 in
clinical normal prostate samples (n = 6) and
BPH samples (n = 22). The blue dotted line
shows average expression levels of CHRM3 in
the normal prostate samples.
(C) Detection of calcium influx by Fluo-4 AM
in BPH1 cells. Carbachol (10 mM) was used
to trigger calcium influx. To counteract
calcium influx, darifenacin (10 mM) was
added 5 min before the stimulation of
carbachol. Scale bar, 200 mm.
(D) Detection of cell proliferation by MTS in BPH1 cells. Carbachol stimulated BPH1 cell proliferation, while both darifenacin and W-7
counteracted the enhanced cell proliferation induced by carbachol (n = 3 experiments).
(E) Western blotting analysis of AKT activation in BPH1 cells. Both darifenacin and W-7 effectively inhibited AKT phosphorylation
stimulated by carbachol. Cells were cultured in serum-free medium and stimulated by 10 mM carbachol for 5 min. In some samples, da-
rifenacin (10 mM) or W-7 (5 mM) was added 1 hr before the stimulation of carbachol. Western blotting images were captured by Quantity
One software.
Data above were analyzed with Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate the SEM.cell proliferation likely via calcium-signaling-mediated
phosphorylation of AKT.DISCUSSION
In this study, we identified the existence of non-neuronal
ACS in developing prostate epithelium. Activation of
ACS promoted the proliferation of epithelial progenitor
cells and inhibited their differentiation to luminal cells.
On the contrary, blockade of CHRM3 effectively inhibited
the proliferation and promoted the differentiation of
epithelial progenitor cells both in vitro and in vivo. In addi-
tion, we proved that ACS regulated prostate development
and epithelial progenitor maintenance in a Ca2+/calmod-
ulin-signaling-dependent manner. Importantly, we found
that CHRM3 was upregulated in a large subgroup of BPH
human prostate samples. We further demonstrated that
activation of CHRM3 promoted BPH cell proliferation
through Ca2+/calmodulin-signaling-mediated phosphory-
lation of AKT. Taken together, our study demonstrates an
important role of non-neuronal ACS in the regulation of
proliferation of prostate epithelial progenitor cells and
BPH cells.
Although several signaling pathways have been re-
ported to regulate postnatal prostate epithelial devel-
opment, including Notch, Hedgehog, Wnt, and FGF
signaling (Shen and Abate-Shen, 2010; Wang et al.,
2003, 2006b, 2008, 2015a), the present study add ACSto the list. On the one hand, similar to other pathways
such as Wnt (Wang et al., 2008), activation of ACS in-
creases the percentage of basal epithelial cells by promot-
ing proliferation and inhibiting differentiation of basal
cells. On the other hand, different from other pathways,
activation of ACS also promotes the proliferation of
luminal cells. We further explored the mechanism of
ACS in regulating prostatic development and found that
ACS likely promotes proliferation of epithelial cells via
calcium-signaling-mediated phosphorylation of AKT. It
would be interesting in future studies to determine
whether there are interactions between the ACS and these
other signaling pathways.
It is important to point out that we performed ex vivo
cell lineage tracing experiments with CK14-CreERT/
Rosa26-RFP mice to study the differentiation of epithelial
progenitor cells. Initially, activation of Cre by 4-OHT only
labeled CK5+ basal cells. However, after 2 days in culture,
there appeared RFP+CK5 differentiated luminal cells that
originated from the RFP+ basal cells. Then we analyzed
the percentage of RFP+CK5 cells over the total RFP-labeled
cells under different culture conditions. We found that
carbachol decreased the percentage of RFP+CK5 cells
over the total RFP+ cells, indicating that carbachol in-
hibited the differentiation of epithelial progenitor cells.
On the contrary, darifenacin and W-7 increased the per-
centage of RFP+CK5 differentiated cells. These findings
reinforce the notion that ACS regulates the differentiation
of prostate epithelial progenitor cells.Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016 675
BPH, an important clinical prostate disease, is a com-
mon prostatic disorder in elderly men. An estimated 40%
of men aged R50 years and >90% of men aged R80
years have microscopic histopathological evidence of BPH
(McNicholas and Kirby, 2011). However, at present, the
cellular and molecular pathology of BPH is still poorly
understood, and better clinical treatment is desired. In the
present study, our findings provided a potential molecular
mechanism for hyperplasia of the epithelial components
of BPH. We found that CHRM3 was upregulated in a
large subset of BPH samples. Activation of CHRM3 pro-
moted BPH1 cell proliferation through promoting Ca2+/
calmodulin-signaling-dependent phosphorylation of AKT.
Together with our previous study reporting an involvement
of ACS in prostate cancer growth and castration resistance
(Wang et al., 2015b), these findings indicate that aberrant
activation of ACS also promotes BPH cell proliferation and
suggest a potential applicationof a selectiveCHRM3 antago-
nist in the treatment of prostate diseases, including not only
prostate cancer but also BPH.EXPERIMENTAL PROCEDURES
Organotypic Cultures of Mouse VPs
Organotypic cultures were performed as previously described
(Leong et al., 2008). VPs were dissected from postnatal day 5 (P5)
mice and placed on 5 mm isopore membrane filters (TMTP02500,
Millipore) in serum-free medium containing DMEM/F12 (Gibco),
100 nM testosterone (T6147, Sigma), insulin-transferrin-sodium
selenite media supplement (I-1884, Sigma), 2 mM glutamine,
100 units/ml penicillin, and 100 mg/ml streptomycin (Gibco).
Carbachol (10 mM, Sigma), darifenacin (10 mM, SantaCruz Biotech-
nology), or W-7 (5 mM, Sigma) was added into the medium at the
beginning of the culture. In some cultures, EdU (10 mM, Thermo
Fisher) was added into the medium 1 hr before fixation. Tissues
were fixed with 4% paraformaldehyde for 30 min on ice, washed
in PBS, and then placed in 30% sucrose before processed for
frozen sectioning. Animal studies were approved and carried out
following the guidelines of Renji Hospital Institutional Animal
Care and Ethics Committee.
Acetylcholine Detection
Acetylcholine concentration wasmeasured using a choline/acetyl-
choline fluorometric kit (K615, BioVision) according to the manu-
facturer’s instructions. P5mouseVPswere isolated and cultured for
2 days, thenweighed, and lysed in 100 ml of choline assay buffer by
supersonic homogenizer before detection. Samples were measured
by fluorescence at Ex/Em = 535/590 nm in a micro-plate reader.
Cell Sorting and Flow Cytometry Analysis
P5mouseVPswerefirst cut into small pieces anddigested in collage-
nase (1 mg/ml) for 1 hr at 37C. After centrifuging, the pellets were
collected anddigestedwith0.25%trypsin-EDTA for 10min todisso-
ciate the epithelial cells. The following primary antibodies were
applied in cell sorting: CD45-fluorescein isothiocyanate (CD45-676 Stem Cell Reports j Vol. 6 j 668–678 j May 10, 2016FITC) (#11-0451, eBioscience), TER119-FITC (#11-5921, eBio-
science), CD31-FITC (#11-0311, eBioscience), EpCAM-PE-cy7
(#25-5791, eBioscience). Unstained samples, EpCAM-PE-Cy7-
stained samples, and lineage-marker-stained samples were used as
negative controls for compensation and FACS gating. Cells were
sorted using a BD FACSAria II machine. To analyze CK5+ basal cells
within the EpCAM+ total epithelial cells, enzymatically separated
cells were first incubated with EpCAM-PE-Cy7 antibody (5 ml per
test). Tubeswerewrapped in aluminumfoil andplaced at room tem-
perature for 30 min. After washing in PBS three times, cells were
fixed with 4% paraformaldehyde (10 min) and permeabilized in
PBS containing 0.5% Triton X-100 (10 min). Then rabbit CK5 anti-
body (PRB-160P, Covance) was added and incubated for 30 min at
room temperature. Cells were washed three times in PBS, prior to
incubation with FITC-conjugated goat anti-rabbit secondary anti-
body (Jackson ImmunoResearch) (30 min at room temperature).
Flow cytometry analysis was performed on the BD FACSAria II
machine.
Renal Capsule Tissue Recombination Assay
UGSM dissociation and renal capsule tissue recombination were
performed as previously described (Leong et al., 2008). Sorted
LinEpCAM+ prostate epithelial cells were cultured in low-attach-
ing 6-well plates and transfected with CHRM3 short hairpin RNA
(shRNA) lentivirus and scrambled shRNA lentivirus. The sequence
of shRNA for Chrm3was 50-CCG AGCCAA ACGAAC AAC AAA-30.
The transfection efficiency was determined by western blot anal-
ysis. Two days after the transfection, 2 mg/ml puromycinwas added
to select the successfully transfected epithelial cells. In each graft,
2,000 epithelial cells were combined with 250,000 UGSM
cells. The samples were prepared in the following order (ten sam-
ples): 103PBS (10ml), 1NNaOH(1.15ml), collagen (50ml,Corning),
cell mixture (38.85 ml in PBS). The samples were incubated at 37C
for 1 hr to allow collagen gelation and overlaid with warm culture
medium overnight at 37C in a cell incubator. The samples were
grafted under the renal capsule of 8-week-old male BALB/c nude
mice. The grafts were harvested 6 weeks after the implantation.
Ex Vivo Lineage Tracing Assay
CK14-CreERT mice (#J006331) were obtained from Nanjing
Biomedical Research Institute of Nanjing University. Rosa26-RFP
mice were obtained from the Jackson Laboratory (#007914). To
activate CreERT, isolated VPs were incubated with 4-hydroxyta-
moxifen (100 nM, Sigma) for 12 hr (Sato et al., 2009). Tissues
were recovered in fresh organ culture medium for 36 hr before
treatment with carbachol and darifenacin.
Immunofluorescent Staining
For fluorescent staining of culturedmouse prostate tissues, 6–8 mm
frozen sections were stained with primary antibodies including
CK5 (SIG-3475 and PRB-160P, Covance), CK8 (MMS-162P, Cova-
nce), CHRM3 (#251652, Abbiotec; sc-9108, Santa Cruz), p63 (sc-
8431, Santa Cruz), Ki67 (ab16667, Abcam), TUJ-1 (T2200, Sigma),
RFP (PM005, MBL) and ChAT (MAB305, Millipore). The primary
antibodies were visualized with Alexa Fluor 488 or 594 conjugated
secondary Fab fragment antibodies (Jackson ImmunoResearch).
Fluorescent images were taken using a Leica DM2500 microscope.
Clinical Sample
Six normal human prostate samples were obtained from bladder
cancer patients. Twenty-two BPH samples were collected from
puncture biopsies. The pathological condition of the BPH samples
was determined by experienced urologists at Ren Ji Hospital. All
prostate samples were obtained from Ren Ji Hospital and collected
with patients’ informed consent.
SYBR Green Real-Time PCR
Total RNA was obtained and reversed to cDNA using the RNeasy
plus Mini Kit and QuantiTect RT Kit (Qiagen). Real-time PCR was
performed using SYBR green PCR reagents from Takara. Real-time
PCR was performed on 7900HT PCR system (ABI). Thermal cycle
conditions included 10 min at 95C to activate DNA polymerase,
40 cycles of 95C for 5 s, and 60C for 30 s. Primer sequences are
listed in Table S1.
Calcium Influx Detection
P3 VPs were anchored to the bottom of 24-well cell culture plates
with 10 ml of Matrigel (354234, BD). Tissues were incubated with
Fluo-4 AM (F-14201, Thermo Fisher, 2 mM in Hank’s balanced
salt solution) for 1 hr at 37C and incubated for another 15 min
in fresh HBSS to allow de-esterification of intracellular AM esters.
Carbachol (50 mM) was used to induce Ca2+ influx, and 10 mM
darifenacin was added 5 min before carbachol to suppress Ca2+
influx. Time-lapse images were taken with a Leica inverted micro-
scope for 300 s with intervals of 6 s. Data were analyzed with
Image-Pro Plus 6.0 software.
Cell Proliferation Detection
The proliferation of BPH1 cells was determined by CellTiter 96
AQueous One Solution Cell Proliferation Assay (MTS) (G3580,
Promega). The experiments were performed following the manu-
facturer’s instructions. Two thousand cells were seeded in 96-well
plats and treated with carbachol, darifenacin, or W-7 for 24 hr.
Twenty microliters MTS working solution was added and cultured
in the incubator for 2 hr. Absorbance was detected at 490 nm.
Western Blot
Cells were lysed in a RIPA buffer (Thermo Fisher) with proteinase
inhibitors (Calbiochem) and phosphatase inhibitors (Roche). The
concentration of total proteins was measured by a BCA method
(ThermoFisher). Primary antibodies againstCHRM3 (#251652,Ab-
biotec), ChAT (MAB305, Millipore), VAChT (BMP048, MBL), AKT
(#4691), p-AKT (Ser473) (#4060), or p-AKT (Thr308) (#13038) (all
AKT antibodies were purchased from Cell Signaling Technology)
were applied, and the membranes were further processed with a
horseradish peroxidase-conjugated secondary antibody (Jackson
ImmunoResearch). ImmunoblotswerevisualizedwithanECLblot-
ting detection kit (Thermo Fisher) and analyzed using Bio-Rad
Quantity One software (version 4.1).
Statistical Analysis
Prostate epithelial branching morphogenesis was measured by
counting the number of branching tips in each of the cultures.
Organotypic cultures were repeated at least three times. All thestatistical values were reported as means ± SEM. Quantification
of immunofluorescent staining was performed by counting the
number of positive cells in the total number of epithelial cells in
fields from more than three different VPs. Results from real-time
PCR and cell proliferation assays were analyzed using a non-para-
metric Student’s t test. Statistical significance was defined as *p <
0.05, **p < 0.01, ***p < 0.001.
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